William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business
-
Moderna, Merck vaccine cuts recurrence and spread of melanoma, raising new treatment hope
-
TJ Maxx, Marshalls 'self-inflicted' slowdown clouds TJX earnings beat
-
Lyntris Inc. Announces Pricing of its Initial Public Offering
-
Saratoga Investment prices $85M in notes due 2031 at 8.00%
-
Saratoga Investment prices $85M in notes due 2031 at 8.00%
-
Saratoga Investment Corp. Prices Public Offering of $85.0 Million 8.00% Notes Due 2031
-
Saratoga Investment Corp. Prices Public Offering of $85.0 Million 8.00% Notes Due 2031
-
Uplift Investors Announces Acquisition of Technology Consultancy Engage fi
-
Arxis completes $770M acquisition of Omnetics Connector
-
Arxis Completes the Acquisition of Omnetics Connector Corporation
-
Saratoga Investment Corp. launches unsecured notes offering on NYSE
-
Saratoga Investment Corp. Announces Offering of Notes and BBB Investment Grade Rating from Egan-Jones Ratings Company
-
William Blair Starts Enliven Therapeutics (ELVN) at Outperform
-
Andersen Group launches secondary offering of 4.28M shares
-
Andersen Announces Launch of Secondary Offering
-
Form N-PX WILLIAM BLAIR FUNDS For: Jun 30
-
Form N-PX WILLIAM BLAIR INVESTMENT For: Jun 30
-
William Blair Downgrades Enovix Corporation (ENVX) to Market Perform
-
Silence Therapeutics closes $201M public offering of ADSs
-
Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Jun 30
-
KKR prices secondary offering of 5 million BridgeBio shares
-
BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base
-
KKR to sell 5 million BridgeBio shares in secondary offering
-
BridgeBio Pharma Announces Launch of Secondary Offering of Common Stock on Behalf of an Existing Shareholder
-
Savers Value Village closes 23M share secondary offering
-
Savers Value Village, Inc. Announces Closing of Upsized Secondary Public Offering of Common Stock and Concurrent Share Repurchase
-
Guggenheim Securities Hires Blake Jones to Expand Global Services Investment Banking Coverage
-
William Blair Downgrades Accelerant Holdings (ARX) to Market Perform
-
Form 13F-HR WILLIAM BLAIR INVESTMENT For: Jun 30
-
William Blair Downgrades Cardiff Oncology (CRDF) to Market Perform
